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Testicular bioenergeticsPre-diabetes, a risk factor for type 2 diabetes development, leads to metabolic changes at testicular level. Perox-
isomeproliferator-activated receptorγ coactivator 1α (PGC-1α) and Sirtuin 3 (Sirt3) are pivotal inmitochondri-
al function. We hypothesized that pre-diabetes disrupts testicular PGC-1α/Sirt3 axis, compromising testicular
mitochondrial function. Using a high-energy-diet induced pre-diabetic rat model, we evaluated testicular levels
of PGC-1α and its downstream targets, nuclear respiratory factors 1 (NRF-1) and 2 (NRF-2), mitochondrial tran-
scription factor A (TFAM) and Sirt3.We also assessedmitochondrial DNA (mtDNA) content, mitochondrial func-
tion, energy levels and oxidative stress parameters. Protein levels were quantiﬁed by Western Blot, mtDNA
content was determined by qPCR.Mitochondrial complex activity and oxidative stress parameters were spectro-
photometrically evaluated. Adenine nucleotide levels, adenosine and itsmetabolites (inosine and hypoxanthine)
were determined by reverse-phase HPLC.
Pre-diabetic rats showed increased blood glucose levels and impaired glucose tolerance. Both testicular PGC-1α
and Sirt3 levels were decreased. NRF-1, NRF-2 and TFAM were not altered. Testicular mtDNA content was
decreased. Mitochondrial complex I activity was increased, whereas mitochondrial complex III activity was
decreased. Adenylate energy charge was decreased in pre-diabetic rats, as were ATP and ADP levels. Conversely,
AMP levels were increased, evidencing a decreased ATP/AMP ratio. Concerning to oxidative stress pre-diabetes
decreased testicular antioxidant capacity and increased lipid and protein oxidation. In sum, pre-diabetes compro-
mises testicular mitochondrial function by repressing PGC-1α/Sirt3 axis and mtDNA copy number, declining
respiratory capacity and increasing oxidative stress. This study gives new insights into overall testicular bioener-
getics at this prodromal stage of disease.
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Pre-diabetes is a major risk factor for the development of type 2
diabetes mellitus (T2DM) and is accompanied by elevated blood glu-
cose levels, although not sufﬁcient to meet the criteria for established
diabetes [1]. It is characterized by impaired fasting glucose (IFG) and/
or impaired glucose tolerance (IGT), and its prevalence is increasing
among young people [1]. Every year, about 5–10% of the individuals
with pre-diabetes become diabetic [2], and population habits may
increase these rates. Moreover, in developed societies, the decrease of
fertility rates has been associated with the increased incidence of
diabetes mellitus (DM) [3]. Indeed, the effect of DM on male fertility
has emerged as an alarming issue, further exacerbated by the increasing
number of children and adolescents with T2DM [4], which present a
transition time between pre-diabetes and T2DM even shorter than
adult individuals [5,6].
336 L. Rato et al. / Biochimica et Biophysica Acta 1837 (2014) 335–344“Western” lifestyle habits, such as overeating and sedentary life,
have contributed to the increased infertility and subfertility prevalence
associated toDM [7,8]. Emerging evidence supports that dietary lifestyle
affects male fertility. For instance, Attaman and collaborators [9]
showed amoderate association between dietary fats and semen quality.
Similarly, Jensen and collaborators [10] also reported that high fat intake
affects sperm count and sperm concentration of Danish men. These
results are also in linewith data from animal studies [11,12], supporting
that saturated fatty acid intake is deleterious for male reproductive per-
formance. The hyperglycemic state resultant from diabetic conditions
contributes for an impaired reproductive function [13–15]. Recently
our team reported that diet-induced pre-diabetes alters testicular
metabolism, compromising sperm quality parameters, with a marked
increase in abnormal sperm morphology [14]. However, little is
known on the molecular mechanisms underlying male reproductive
dysfunction in the diet-induced pre-diabetic state. Mitochondria are
the best-known cellular powerhouses and form an interconnected
network that is integrated with other cellular compartments. This
organelle is of great importance, since it is essential for functional
sperm, and thus, to ensure a normal spermatogenic event. Peroxisome
proliferator-activated receptor gamma coactivator 1-α (PGC-1α) is a
member of a small family of transcriptional regulators which controls
the expression of genes involved in energy homeostasis, mitochondrial
biogenesis, fatty acid oxidation and glucose metabolism [16,17]. PGC-
1α stimulates the expression of transcriptional regulators, the nuclear
respiratory factors 1 and 2 (NRF-1 and NRF-2) that act on the nuclear
genes coding for subunits of the oxidative phosphorylation (OXPHOS)
system. Mitochondrial transcription factor A (TFAM) is a downstream
target of both NRF-1 and NRF-2 that activates the transcription via
sequence speciﬁc binding in the mitochondrial promoters [18]. TFAM
gene presents consensus-binding sites for both NRF-1 and NRF-2 pro-
viding a unique mechanism for the cell integrates the expression of
nuclear DNA-encoded proteins with the transcription of genes encoded
by mtDNA [18]. Undoubtedly, PGC-1α is pivotal for mitochondrial
function, as well as for the expression of key mitochondrial proteins,
such as Sirtuin 3 (Sirt3) [16]. Sirt3 is a member of sirtuins family of
NAD+-dependent class III histone deacetylases and/or protein ADP-
ribosyltransferases that mediate adaptive responses to a variety of
stresses [19]. Among the seven members of the sirtuins family, Sirt3 is
of particular interest concerning the mitochondrial function, as this
protein is preferentially allocated in this organelle [19]. Similarly to
PGC-1α, Sirt3 promotes metabolic reprogramming by activating en-
zymes involved in mitochondrial fuel catabolism [20]. Sirt3 modulates
mitochondrial energy homeostasis by regulating ATP generation from
OXPHOS [21] and interacts with the enzymatic complexes of the elec-
tron transport chain (ETC), resulting in increased activity of complexes
and contributing to an efﬁcient electron ﬂow through ETC [22]. Interest-
ingly, PGC-1α and Sirt3 act synergistically to maintain mitochondrial
biogenesis, functional OXPHOS and an active ROS defense system [16].
It has been reported that PGC-1α and Sirt3 are downregulated in the
skeletal muscle of high-fat fed rats [23], and the lack of PGC-1α and/or
Sirt3 favors oxidative stress, due to an imbalance between ROS and an-
tioxidant defenses [24]. ROS overproduction damages mtDNA, which
compromises the expression of OXPHOS genes resulting in a mitochon-
drial respiratory dysfunction.
Herein we hypothesize that PGC-1α/Sirt3 axis could play a major
role in testicular bioenergetic metabolism and ultimately in spermato-
genesis of pre-diabetic individuals. Available information concerning
mitochondrial testicular bioenergetics in DM is often associated with
more advanced or severe stages of the disease [25] and there are no
studies at the initial stages of this pathology. Thus, using a high-
energy diet (HED) male rat model that develops a pre-diabetic state,
we aimed to evaluate the effects of pre-diabetes on testicular expression
of PGC-1α and its downstream targets Sirt3, NRF-1, NRF-2, TFAMandon
testicular ETC function. We also evaluated the effects on testicular
mtDNA integrity, testicular adenylate energy charge (AEC) and onparticular oxidative stress parameters, such as antioxidant capacity,
lipid peroxidation and carbonyl content.2. Material and methods
2.1. Chemicals
DNeasy® Blood & Tissue kit (Cat. Nº 69504, Qiagen, Hilden,
Germany), Maxima SYBR Green qPCR Master Mix (Fermentas, Vilnius,
Lithuania), DCPIP (D1878, Sigma-Aldrich, St Louis, MO, USA), NADH
(N6005, Sigma-Aldrich, St Louis, MO, USA); Coenzyme Q1 (C7956,
Sigma-Aldrich, St Louis, MO, USA), Decylubiquinone (D7911, Sigma-
Aldrich, St Louis, MO, USA), cytochrome c (C30398, Sigma-Aldrich,
St Louis, MO, USA), n-Dodecyl β-D-maltoside (D4641, Sigma-Aldrich,
St Louis, MO, USA), protease cocktail inhibitor (P8340, Sigma-Aldrich,
St Louis, MO, USA), anti-Sirt3 polyclonal antibody was purchased at
Cell Signaling (Beverly, USA), anti-PGC1-α, anti-TFAM and anti-NRF-1
were purchased at Santa Cruz Biotechnology, Inc. (USA), and anti-
NRF-2 was purchased at Abcam (Cambridge, UK). ECFTM substrate was
purchased at GE, Healthcare (Orsay, France). All other chemicals were
purchased at Sigma-Aldrich (St Louis, MO, USA).2.2. Animals
In the present study, we used 12 two-month-old male Wistar rats
(Charles River Laboratories, Barcelona, Spain). The animalswere housed
in our accredited animal colony (Health Sciences Research Centre, Uni-
versity of Beira Interior) and maintained on ad libitum food and water,
at constant temperature (20 ± 2 °C) and with a 12-hour cycle of artiﬁ-
cial lighting. All animal experiments were performed according to the
“Guide for the Care and Use of Laboratory Animals” published by the
US National Institutes of Health (NIH Publication No. 85–23, revised
1996) and the European rules for the care and handling of laboratory
animals (Directive 86/609/EEC).2.3. Animal model and experimental design
Rats were randomly divided (6 per group) in control and high-
energy diet (HED) groups. In control group, animals were fed with a
standard chow diet (4RF21 certiﬁcate, Mucedola, Italy), while HED
group received an additional high-energy emulsion, as described else-
where [14,26–28]. Brieﬂy, in the ﬁrst 5 days of treatment, animals
were given progressively 1 to 5 mL of emulsion by gavage consisting
of 20 g lard oil, 1 g thyreostat, 5 g cholesterol, 1 g sodium glutamate,
10 g sucrose, 20 mL Tween 80, 30 mL propylene glycol, prepared in a
ﬁnal volume of 100 mL by adding distilled water. Then, they were
administrated daily with 5 mL of the emulsion until reaching one
month of treatment. Water was administered to the respective control
group.
Animal's blood glucose levels were monitored every 6 days. After
treatment, animals were killed by cervical dislocation. Blood was
collected by cardiac puncture to non-heparinized tubes. Testicles were
removed, weighed and stored at−80 °C. Non-fasting glycaemia was
determined using a glucometer (One Touch Ultra Lifescan-Johnson,
Milpitas, CA, USA) and insulin levelsweredetermined using commercial
rat EIA kits (Mercodia, Uppsala, Sweden), according to the
manufacturer's instructions.
At 3 months of age, animals were submitted to a glucose tolerance
test, as described by Rato and collaborators [14]. Brieﬂy, 14–18 h before
the test, food was removed and animals were kept in fasting. An intra-
peritoneal injectionwith 6 mL glucose 30% (w/v) per kg of bodyweight
was given to each animal. Blood glucose levels weremeasured at 30, 60,
90 and 120 min after glucose loading. The area under the curve for glu-
cose tolerance (AUCg) was calculated using trapezoidal rule.
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Western Blot procedure was performed as previously described by
Simões and collaborators [29]. The resulting membranes were incubat-
ed with rabbit anti-PGC-1α (1:1000, sc-13067, Santa Cruz Biotechnolo-
gy), rabbit anti-NRF-1 (1:1000, sc-33771, Santa Cruz Biotechnology),
goat anti-TFAM (1:500, sc-23588, Santa Cruz Biotechnology), rabbit
anti-NRF-2 (1:1000, ab31163, Abcam), rabbit anti-Sirt3 (1:1000,
C73E3, Cell Signaling Technology Inc.) or mouse anti-tubulin (1:5000,
T9026, Sigma-Aldrich) was used as protein loading control for testicular
tissue. The immuno-reactive proteins were detected separately with
goat anti-rabbit IgG-AP (1:5000, Sc2007, Santa Cruz Biotechnology) or
goat anti-mouse IgG-AP (1:5000, Sc2008, Santa Cruz Biotechnology)
or rabbit anti-goat IgG-AP (1:20000, A4187 Sigma-Aldrich). Mem-
branes were reacted with ECFTM detection system (GE, Healthcare).
The densities from each band were obtained using the Quantity One
Software (Bio-Rad, Hemel Hempstead, UK), divided by the respec-
tive tubulin band density and then normalized against the respec-
tive control.
2.5. mtDNA relative copy number
Total DNA was extracted from tissues using the DNeasy® Blood &
Tissue kit, according to the manufacturer's instructions.
mtDNA relative copy number of the experimental groupswas deter-
mined by qPCR analysis, as described byWai and collaborators [30]with
slight modiﬁcations. Relative quantiﬁcation of mtDNA levels was deter-
mined by the ratio between the mitochondrial ND1 (mtND1) gene and
the single-copy, nuclear-encoded beta-2-microglobulin (β2MG) gene.
Reactions were carried out in an iQ5 system (Bio-Rad, Richmond, CA,
USA), and the efﬁciency of the reactions was determined for the select-
ed primers using serial dilutions of DNA samples. The speciﬁcity of the
ampliconswas determined bymelting curve analysis. The reactionmix-
ture consisted ofMaxima SYBRGreen qPCRMasterMix, 200 nMof each
sense and antisense primers (see Table 1 for details) and 20 ng of DNA.
Each reaction was run in triplicate to calculate relative mtDNA copy
number. Ct values of all samples were within the linear range. Ct
value differences were used to quantify mtDNA copy number rela-
tive to the β2MG gene with the following equation: Relative copy
number = 2-ΔΔCt, where ΔCt is Ctβ2MG − CtND1.
2.6. Citrate synthase activity
Citrate synthase activity was determined bymodiﬁcation of a meth-
od previously described by Core and collaborators [31]. Brieﬂy, testicu-
lar tissue was homogenized using lysis buffer (250 mM Sucrose,
5 mM HEPES, pH 7.4). Protein concentration was determined by the
Bradford micro assay using BSA (bovine serum albumin) as a standard.
25 μg of tissue homogenate was incubated at 37 °C in a reaction buffer
containing 100 mM Tris pH 8.0 plus 200 μM Acetyl-CoA, 200 μM 5,5′-
dithiobis-2-nitrobenzoic acid. Enzymatic activity was determined in a
VICTOR X3 plate reader (Perkin-Elmer Cetus, Norwalk, CO, USA), at
37 °C, by following the increase in absorbance (412 nm) upon addition
of 100 μM freshly-prepared oxaloacetate. Enzyme activity was calculat-
ed through the mean of the slopes of duplicates obtained during the
linear phase. Citrate synthase-speciﬁc activity was calculated byTable 1
Oligonucleotides and cycling conditions for qPCR ampliﬁcation of ND1 and β-2-
microglobulin.
Gene Sequence (5′–3′) AT (°C) Amplicon size (bp)
ND1 Sense: GAG CCC TAC GAG CCG TTG CC 58 271
Antisense: GCG AATG GTC CTG CGG CGT A
β2MG Sense: GCG TGG GAG GAG CAT CAG GG 58 264
Antisense: CTCATCACCACCCCGGGGACT
Abbreviations: AT— annealing temperature.subtracting the basal activity in the presence of 0.1% Triton-X100. A
molar extinction coefﬁcient of ε412 = 13.6 mM−1·cm−1 and normali-
zation to protein amount were applied. Enzyme activity was expressed
as nmol of oxaloacetate min−1·mg protein−1.
2.7. NADH-ubiquinone oxidoreductase activity
Complex I activity was determined bymodiﬁcation of amethod pre-
viously described by Long and collaborators [32]. Brieﬂy, 30 μg of tissue
homogenate (obtained as previously described) was diluted in reaction
buffer containing 25 mM KH2PO4 pH 7.5, 5 mM MgCl2, 300 μM KCN,
4 μM antimycin A, 3 mg·mL−1 BSA, 60 μM coenzyme Q1, 160 μM 2,6-
dichlorophenolindophenol (DCPIP). Complex I activity was measured
at 37 ºC, in a VICTORX3plate reader, by following the decrease in absor-
bance (600 nm) of DCPIP upon addition of 100 μM freshly-prepared
NADH. Enzyme activity was calculated through the mean of slopes of
duplicates, obtained during the linear phase. Mitochondrial complex I
speciﬁc activitywas determined as the difference betweenbasal activity
in the absence or presence of 10 μM rotenone (speciﬁc inhibitor of
complex I). A molar extinction coefﬁcient of ε600 = 19.1 mM−1.cm−1
and normalization to protein amount were applied. Complex I activity
was expressed as nmol DCPIP min−1·mg protein−1.
2.8. Succinate-cytochrome c reductase activity
Complex II/III activity was determined by modiﬁcation of a method
previously described by Tisdale [33]. Brieﬂy, 100 μg of tissue homoge-
nate (obtained as described above) was preincubated for 5 min, at
37 °C, in 200 μL of phosphate buffer (166 mM KH2PO4/K2HPO4,
pH 7.4) supplemented with 100 mM KCN and 500 mM sodium succi-
nate. The reaction was initiated by the addition of 120 μL of phosphate
buffer supplemented with 2 mM oxidized cytochrome c (cyt cox) plus
15 mM EDTA-dipotassium. Enzyme activity was calculated through
themean of slopes of duplicates, obtained during the linear phase. Com-
plex II/III activity was measured by following the reduction of cyt cox
(increased absorbance at 550 nm), using a VICTOR X3 plate reader. Mi-
tochondrial complex II/III speciﬁc activity was determined as the differ-
ence between basal activity in the absence or presence of 4 mM
antimycin A (speciﬁc inhibitor of complex III). A molar extinction coefﬁ-
cient of ε550 = 19.1 mM−1·cm−1 and normalization to protein amount
were applied. Resultswere express as nmol cyt cox min−1·mg protein−1.
2.9. Cytochrome c reductase activity
Complex III activity was determined by modiﬁcation of a method
previously described Luo and collaborators [34]. Brieﬂy, 100 μg of tissue
homogenate (obtained as previously referred) was incubated in reac-
tion buffer containing 25 mM KH2PO4 pH 7.5, 4 uM rotenone, 0.025%
Tween-20, 100 μM fresh decylubiquinone solution at 37 °C. Enzymatic
activity was followed by an increase in absorbance of cyt cox at
550 nm, upon addition of 75 μM cyt cox in a VICTOR X3 plate reader.
Enzyme activity was calculated through the mean of slopes of dupli-
cates, obtained during the linear phase. Mitochondrial complex III spe-
ciﬁc activity was determined as the difference between basal activity
in the absence or presence of 2.5 mM antimycin A (complex III speciﬁc
inhibitor). A molar extinction coefﬁcient of ε550 = 19.1 mM−1·cm−1
and normalization to protein amount were applied to express the activ-
ity as nmol cyt cox min−1·mg protein−1.
2.10. Cytochrome c oxidase activity
Complex IV activity was determined by modiﬁcation of a method
previously described by Brautigan and collaborators [35]. Brieﬂy, 25 μg
of tissue homogenate (obtained as previously described)was incubated
at 37 °C, in reaction buffer containing 50 mM KH2PO4 pH 7.0, 4 μM
antimycin A, 0.05% n-dodecyl-β-D-maltoside. Enzymatic activity was
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at 550 nm, upon addition of 57 μM freshly-prepared cyt cred in a
VICTOR X3 plate reader. Enzyme activity was calculated through the
mean of slopes of duplicates, obtained during the linear phase. Mitochon-
drial complex IV speciﬁc activity was determined as the difference
between basal activity in the absence or presence of 10 mM of KCN
(complex IV speciﬁc inhibitor). A molar extinction coefﬁcient of
ε550 = 19.1 mM−1·cm−1 and normalization to protein amount were
applied. Activity was expressed as nmol cyt cred min−1·mg protein−1.
2.11. Analysis of adenine nucleotides and adenosine metabolites
Adenine nucleotide and adenosinemetabolite levels weremeasured
according to previously described methods by Rego and collaborators
[36]. Brieﬂy, testicular tissue was homogenized in lysis buffer
(250 mM sucrose, 20 mM HEPES, 10 mM KCl, 1.5 mM MgCl2, 1 mM
EDTA, 1 mM EGTA, pH 7.4) supplemented with 1% protease inhibitor
cocktail, 1 mM DTT and 1 mM PMSF and centrifuged at 14,000 ×g, for
2 min at (0–4 °C). After neutralizationwith 3 MKOH in 1.5 MTris, sam-
ples were centrifuged at 14,000 ×g for 2 min (0–4 °C). The resulting
supernatants were used to determine protein concentration by the
Bradford micro assay using BSA as a standard. The supernatant
was assayed for ATP, ADP, AMP, adenosine and its metabolites (inosine
and hypoxanthine), by separation in a reverse-phase high-performance
liquid chromatography (HPLC), as described by Stocchi and collabora-
tors [37]. The chromatographic apparatus used was a Beckman-
System Gold (Beckman Instruments, Fullerton, USA), consisting of a
126 Binary Pump Model and 166 Variable UV detector, controlled by a
computer. The detection wavelength was 254 nm, and the column
used was a LiChrospher 100 RP-18 (5 μm) from Merck (Darmstadt,
Germany). An isocratic elution with 100 mmol/L phosphate buffer
(KH2PO4; pH 6.5) and 1.0% methanol was performed with a ﬂow rate
of 1 mL/min. The required time for each analysis was 6 min. Peak iden-
tity was determined by the retention time compared with standards.
The amounts of nucleotides and metabolites were determined by a
concentration standard curve. Testicular AECwas determined according
to the formula: ATP + 0.5 × ADP /(ATP + ADP + AMP).
2.12. Ferric reducing antioxidant power assay
The ferric reducing antioxidant power (FRAP) of the media samples
was performed according to the colorimetric method described by
Benzie and Strain [38]. Brieﬂy, testicular tissue was homogenized in
phosphate buffer (pH 7.4). Protein concentration was determined by
the Bradford micro assay using BSA as a standard. Working FRAP
reagent was prepared by mixing acetate buffer (300 mM, pH 3.6),
2,4,6-Tripyridyl-s-Triazine (TPTZ) (10 mM in 40 mM HCl) and FeCl3
(20 mM) in a 10:1:1 ratio (v:v:v). 180 μL of this reagent was mixed
with 10 μg of tissue homogenate. The reduction of the Fe3+-TPTZ
complex to a colored Fe2+-TPTZ complex by the samples was moni-
tored immediately after adding the sample and 40 min later, by mea-
suring the absorbance at 595 nm using an Anthos 2010 microplate
reader (Biochrom, Berlin, Germany). Antioxidant potential of the
samples was determined against standards of ascorbic acid, which
were processed in the samemanner as the samples. Absorbance results
were corrected by using a blank, with H2O instead of sample.
2.13. Thiobarbituric acid reactive species assay
Thiobarbituric acid reactive species (TBARS) are formed as a
byproduct of lipid peroxidation, which can be detected by the TBARS
assay using thiobarbituric acid (TBA) as a reagent. This peroxidation
reaction producesmalonaldehyde (MDA) that reacts with TBA in condi-
tions of high temperature and low pH, generating a pink colored com-
plex, which absorbs at 532 nm [39]. TBARS assay was carried out by
the method described by Iqbal and collaborators [40] with slightmodiﬁcations. Testicular tissue was homogenized in phosphate buffer
(pH 7.4). Protein concentration was determined by the Bradford
micro assay using BSA as standard. Brieﬂy, 20 μg of tissue homogenate,
0.01 mL Tris–HCl buffer (150 mM, pH 7.1), 0.01 mL ferrous sulphate
(1.0 mM), 0.01 mL ascorbic acid (1.5 mM) and 0.06 mL H2O were
mixed in a reaction tube. This mixture was incubated at 37 °C for
15 min. The reaction was stopped by addition of 0.1 mL of trichloroace-
tic acid (10% w/v). Subsequently, 0.2 mL of TBA (0.375% w/v) were
added and all samples were incubated for 15 min at 100 °C. Finally,
samples were centrifuged at 1000 ×g for 10 min. The amount of MDA
formed in each sample was estimated by measuring optical density at
532 nm using a UV–VIS spectrophotometer (Shimadzu, Kyoto, Japan)
against a blank. The results were expressed as nmol of TBARS/mg
protein.2.14. Analysis of carbonyl groups
Protein carbonyl content is commonly used as a marker for protein
oxidation. To evaluate protein carbonyl groups a Slot Blot was performed.
First, samples were derivatized using 2,4-dinitrophenylhydrazine
(DNPH) according to themethod developed by Levine and collabora-
tors [41]. Brieﬂy, a volume containing 40 μg of lyophilized testicular
tissue homogenized in phosphate buffer was mixed with the same
volume of SDS 12% and centrifuged tominimize nucleic acid interfer-
ence in the assay. The samples were thenmixed with two volumes of
DNPH 20 mM diluted in TFA 10% and incubated for 30 min in a dark
environment. The reaction was stopped using 1.5 volumes of Tris
2 M diluted in β-mercaptoethanol. Samples were then diluted to a
concentration of 0.001 μg/μL using phosphate buffer. A previously acti-
vated polyvinylidenediﬂuoride membrane was used in the Slot-Blot,
which was performed in a Hybri-slot manifold system (Biometra,
Germany). The membranes were then incubated for 90 min with a 5%
non-fat milk solution. Afterwards, membranes were incubated over-
night with rabbit anti-DNP antibody (1:5000 D9656; Sigma Aldrich).
Samples were visualized using anti-rabbit IgG-AP. Membranes were
then reacted with ECFTM substrate (GE, Healthcare) and read using a
BioRad FX-Pro-plus (Bio-Rad, UK). Densities from each band were
quantiﬁed using the BIO-PROFIL Bio-1D Software from Quantity One
(VilberLourmat, Marne-la-Vallée, France).2.15. Statistical analysis
The statistical signiﬁcances of the differences between all experi-
mental data were assessed by unpaired Student's t-test (GraphPad
Software, San Diego, CA, USA). All experimental data are shown as
mean ± SEM of the indicated number of independent experiments.
P b 0.05 was considered signiﬁcant.3. Results
3.1. High-energy diet fed rats developed mild hyperglycemia, glucose
intolerance and hypoinsulinemia
HED rodent model was developed as previously described by our
team [14,42]. At the end of HED treatment, animals presented mild
hyperglycemia (Fig. 1A).Moreover, HED rats had signiﬁcantly increased
(by ~57%) AUCg values compared to control group (Fig. 1B), evidencing
that HED rats developed signiﬁcant glucose intolerance. These results
suggested an insulin dysfunction status, so we measured fasting
blood insulin levels and, as expected, insulin levels of HED rats
were signiﬁcantly decreased (by ~61%) when compared to control
group (Fig. 1C). These characteristics, particularly glucose intoler-
ance and mild-hyperglycaemia, indicated that HED animals devel-
oped a pre-diabetic state.
Fig. 1.A)Blood glucose levels of control group andHEDgroup animals after 30 days of treatment. B) AUCgof the intraperitoneal glucose tolerance test performed in control group andHED
group animals. C) Insulin levels of control group and HED group animals after 30 days of treatment. Results are presented asmean ± SEM of six independent experiments, corresponding
to six animals/group. *P b 0.05 vs. control group. HED—high-energy diet. AUCg—area under the curve for glucose tolerance test.
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decreasing PGC-1α protein levels
High-energy diets are known to downregulate PGC-1α protein
levels [23], thus we evaluated the effects of pre-diabetes in testicular
PGC-1α protein levels and we observed a 1.53-fold reduction in HED
animals when compared to control group (Fig. 2; Panels A and B). As
PGC-1α is considered the key regulator of mitochondrial biogenesis,
the decreased levels of PGC-1αmay compromise this cellular process,
so we quantiﬁed the protein levels of its downstream targets: NRF-1,
NRF-2 and TFAM. The obtained results showed no differences between
groups for both nuclear transcriptors NRF-1 and NRF-2, as well as, the
key activator of mitochondrial transcription and mtDNA replication,
TFAM (Fig. 2; Panels A and B).
3.3. Pre-diabetes signiﬁcantly decreased testicular levels of Sirtuin 3
In addition, since PGC-1α is crucial for the expression of Sirt3, we
further quantiﬁed the protein levels of this mitochondrial deacetylase.
Sirt3 is the most important deacetylase that modulates mitochondrial
metabolism and oxidative stress [24]. Sirt3 protein levels were
decreased by 2-fold in HED animals when compared to control group
(Fig. 2; Panels A and B). The decreased levels of testicular Sirt3 may
contribute to a compromised testicular mitochondrial function andFig. 2. Effect of high-energy diet (HED) on testicular PGC-1α, Sirt3, NRF-1, NRF-2 and
TFAM protein (Part A) levels. Part B represents an illustrative Western Blot experiment.
Results are presented as mean ± SEM of ﬁve independent experiments, corresponding
to ﬁve animals/group and performed in triplicate. *P b 0.05 vs. control group.increased oxidative stress, so we further assessed mitochondrial func-
tion and oxidative stress parameters.
3.4. Pre-diabetes signiﬁcantly decreased testicular mtDNA copy number
mtDNA comprises genes encoding for polypeptides that constitute
the multi-subunit enzyme complexes of the respiratory chain. Alter-
ations in mtDNA content have been associated to disturbances in the
activity of ETC [43]. Therefore, we determined the effects of HED on
testicular tissue mtDNA content. We observed a 38.8% decrement in
mtDNA content in HED rat testicles compared to control group (Fig. 3;
Panel A). This suggests that mitochondrial respiratory function may be
affected in these conditions. Thus, we determined ETC complexes activ-
ity in order to evaluate possible testicular mitochondrial bioenergetics
alterations induced by pre-diabetes.
3.5. Mitochondrial complex I and complex III activities were altered in
testicles of pre-diabetic rats
Mitochondrial function is highly dependent on the activities of sev-
eral mitochondrial enzymes, such as citrate synthase and respiratory
complexes I to IV. Citrate synthase activity is a marker for testicular mi-
tochondrial content and integrity [31]. In this regard, we did not ﬁnd
signiﬁcant differences in testicular tissue from animals of both groups
(Fig. 3; Panel B).
We also evaluated the enzymatic activities of mitochondrial re-
spiratory complexes I to IV (Fig. 3C–F). Despite no signiﬁcant differ-
ences in both succinate cytochrome c reductase (complex II-III) and
cytochrome c oxidase (complex IV) activities in testicular tissue from
animals of both groups (Fig. 3D and F), NADH reductase (complex I)
activity was increased by 79% in HED rat testicles compared to con-
trol (Fig. 3C). Testicular cytochrome c reductase (complex III) activ-
ity of HED rats was decreased from 448 ± 97 nmol/min (in control
rats) to 236 ± 73 nmol/min (Fig. 3E).
3.6. Testicular adenylate energy charge was signiﬁcantly decreased by pre-
diabetes
Testicles are organs with high-energy demands and the AEC is often
used to evaluate overall energetic status of cells and tissues [44,45].
Thus, we analyzed the HED effect in adenine nucleotides metabolism
and in testicular AEC. ATP content was 39% lower in testicles of HED
than in control rats (Fig. 4A). Likewise, ADP content in testicular tissue
of HED rats showed a signiﬁcant decrease (by 56%) when compared
with control animals (Fig. 4B). Conversely, testicular AMP content
was increased by 89% in HED rats (Fig. 4C). As a consequence of the
lower levels of ATP and the signiﬁcant increase in AMP content, lower
ATP/AMP ratio in testicles of HED rats when compared with control
animals (Fig. 4D) was detected.
Fig. 3.A) RelativemtDNA copy number in control group and HED group. B) Citrate synthase activity; C) NADH reductase (Complex I) activity; D) succinate cytochrome c reductase (Com-
plex II/III) activity; E) cytochrome c reductase (Complex III) activity; F) cytochrome c oxidase (Complex IV) activity. Results are presented as mean ± SEM of ﬁve independent experi-
ments, corresponding to ﬁve animals/group and performed in triplicate. *P b 0.05 vs. control group.
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HED rats when compared to control animals (Fig. 4E). The lower testic-
ular AEC level in HED rats points to low energy levels in testicularmilieu,
with a high accumulation of AMP.
3.7. Pre-diabetes alters testicular adenosine metabolites
The lower testicular ATP/AMP observed in HED rats leads us to
hypothesize that ATP metabolism should be progressing to adenosine
formation. In fact, the conversion of AMP to adenosine is aﬁnal common
step in the catabolism of the adenine nucleotides [46]. Herewith, we did
not observed signiﬁcant differences on the testicular adenosine levels
between animals from both groups (Table 2). Interestingly, we foundFig. 4. Testicular adenine nucleotides levels in control group and HED group. A) ATP; B) ADP; C
mean ± SEM of ﬁve independent experiments, corresponding to ﬁve animals/group and perfothat inosine content was decreased by 54% in testicles of HED rat com-
pared with the animals from the control group (Table 2), while
hypoxanthine content raised by 24% in HED animals compared to
control animals (Table 2). These results suggest that pre-diabetes favors
adenine nucleotides metabolism in which AMP is converted to adeno-
sine subproducts, namely hypoxanthine, suggesting an oxidative state.
3.8. Pre-diabetes favors testicular oxidative environment
To evaluate the effects of pre-diabetes on testicular antioxidant
capacity we utilized the FRAP assay. The FRAP assay measures the
potential to reduce ferric (III) to ferrous (II) in a redox-linked colorimet-
ric reaction that involves single electron transfer [38]. This reducing) AMP; D) ATP/AMP ratio; E) Testicular adenylate energy charge. Results are presented as
rmed in duplicate. *P b 0.05 vs. control group.
Table 2
Average values of the testicular adenosine metabolites measured in Control group and in
HED group.
Adenosine metabolites Control group HED group
Adenosine (pmol/mg tissue) 7.34 ± 0.72 6.74 ± 0.26
Inosine (pmol/mg tissue) 49.89 ± 2.21 23.19 ± 4.88⁎
Hypoxanthine (pmol/mg tissue) 137.07 ± 3.17 170.97 ± 5.25⁎
HED: high-energy diet. Results are expressed as means ± SEM (n = 5 for each
condition).
⁎ Signiﬁcantly different relative to control (P b 0.05).
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ity (FRAP value). The results showed that antioxidant capacity was de-
creased by 55% in testicles of HED animals when compared to control
group (Fig. 5A). The decreased antioxidant capacity in HED rat testicles
may favor a high testicular ROS activity.Fig. 5. A) Testicular antioxidant capacity in control group and HED group. B) Testicular
lipid peroxidation in control group and HED group. C) Testicular carbonyl content in
control group and HED group. D) Illustrative representation of carbonyl content by Slot
Blot. Results are presented asmean ± SEM of ﬁve independent experiments, correspond-
ing to ﬁve animals/group and performed in duplicate. *P b 0.05 vs. control group.Testicles present high lipid content, which are known to be a major
target of ROS. Increased testicular ROS activity may lead to lipid perox-
idation, therefore we evaluated the TBARS content in testicular homog-
enates as a measure of lipid peroxidation. We observed a signiﬁcant
increase of testicular TBARS content from 0.0166 nmol/mg tissue (in
control group) to 0.0498 nmol/mg tissue in HED group (Fig. 5B).
These results demonstrate a 3-fold increase on testicular lipid peroxida-
tion levels in testicles of HED-fed rats.
As it occurs for lipids, proteins are also sensitive to oxidation by ROS.
The evaluation of protein carbonyl groups content has beenwidely used
as biomarker of protein damage by oxidative stress [47]. As pre-diabetic
animals presented an alteration on testicular antioxidant capacity, we
evaluated the effect of pre-diabetes on testicular protein oxidation.
Hence, animals from the HED group exhibited a 26% increase of testicu-
lar carbonyl content when compared to control group (Fig. 5C and D).
4. Discussion
Pre-diabetes is a pathological state that includes some (but not all)
diagnostic criteria for DM [1], being characterized by IFG and/or IGT
and by mild hyperglycemia [2]. In the present study, a HED-induced
rodent model was used to evaluate the effects of this prodromal stage
of DM in testicular PGC-1α/Sirt3 axis, aswell as inmitochondrial bioen-
ergetics and oxidative stress. As described by our team, this HED-fed
rodent model displayed the characteristics of a pre-diabetic state as
reported in other studies using the same animal model [14,26]. As
expected, the HED fed animals developed mild hyperglycaemia and
glucose intolerance, which are the two main characteristics of a pre-
diabetic state. The mild hyperglycaemia observed in the HED animals
did notmeet the criteria for established DM [48]. However, those condi-
tions together with the lower insulin levels, point toward a higher risk
for DM [49,50]. The observed decrease in insulin levels may be caused
by β-cell pancreatic failure. This hypothesis is supported by studies
from Blazquez and Quijada [51], which observed hypoinsulinemia in
high-fat fed animals. In fact, β-cells may present certain susceptibility
to lipids [52], thus the dietary fats used in HED may induce β-
pancreatic cell failure, decreasing insulin secretion. Furthermore,
impaired insulin secretion has also been described in adolescents with
pre-diabetes, particularly those with a higher BMI, presenting a higher
risk for progression to T2DM [53].
The well-functioning of the PGC-1α/Sirt3 axis has been reported as
essential for the regulation of mitochondrial metabolism, biogenesis
and oxidative stress [16,54]. PGC-1α arises as a key regulator of mito-
chondrial function, since it co-activates several nuclear transcriptors,
which in turn regulate the expression of nuclear encodedmitochondrial
proteins. PGC-1α is also essential for the expression of Sirt3. Recently
Kong and collaborators [16] showed that PGC-1α knockdown effective-
ly reduces Sirt3 expression in muscle cells and hepatocytes, which reg-
ulates important mitochondrial functions by deacetylating several
metabolic and respiratory enzymes [19,22]. Disturbances of PGC-1α
levels have been linked to the development of DM [55]. Furthermore,
it has also been reported that Sirt3 is decreased by high-fat consumption
[56,57], as well as under diabetic conditions [24], which is concomitant
with PGC-1α decrease [23].
In our work we identiﬁed the expression of PGC-1α and Sirt3 on the
testicles of 3-month old Wistar rats. Importantly, we found that at
testicular level both the PGC-1α and Sirt3 protein levels were signiﬁ-
cantly decreased on the animals of the HED group. This decrease in
PGC-1α levelsmay be deleterious for testicular mitochondrial physiolo-
gy, particularly because this effect can be exacerbated by downregula-
tion of Sirt3. Our results suggest that the reduced expression of PGC-
1α compromises the expression of Sirt3 in the testicles of HED-fed
rats. Although, to the date, there are no direct reports demonstrating
that down-regulation of PCG-1α leads to reduced SIRT3 levels within
testicularmilieu, Kong and collaborators recently described a molecular
mechanism for Sirt3 expression, where PGC-1α functions as an
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cytes, having a stimulatory effect on Sirt3 promoter [16]. The results
obtained herein suggest that the reduced expression of PGC-1α com-
promises the expression mechanism of Sirt3, thus decreasing testicular
Sirt3 content. So, in these conditions the expression of testicular Sirt3
may be downregulated at transcriptional level, leading to a decreased
Sirt3 protein levels.
Decreased levels of PGC-1α and Sirt3 are known to modulate mito-
chondrial metabolic activity and oxidative stress regulatory pathway
activation [19,56]. We have previously reported that the high glycolytic
ﬂux evidenced by HED animals favored an oxidative environmentwith-
in testicles [14], which could compromise cellular integrity. In this con-
text, PGC-1α is required to the induction of ROS-detoxifying enzymes
under oxidative stress conditions [16], whereas PGC-1α knockdown
blunts antioxidant capacity [58]. Recently Kong and collaborators [16]
showed that PGC-1α acts as a ROS suppressor by increasing the expres-
sion of glutathione peroxidase 1 and superoxide dismutase 2 [54,59].
Additionally, it has also been reported that Sirt3 induces the expression
of antioxidant defenses [60], thus mediating the effects of PGC-1α on
ROS levels. This highlights the synergistic role between PGC-1α and
Sirt3 in the control of the oxidative stress status [16]. Indeed, HED-fed
rats presented a deﬁcient testicular antioxidant capacity, which may
result in part from the signiﬁcant deregulation of the PGC-1α/Sirt3
axis, thus enhancing testicular ROS overproduction. Our results show
an increased level of carbonyl content and TBARS in testicles of HED
rats, evidencing a higher testicular susceptibility to oxidation associated
with pre-diabetes. In fact the decreased levels of Sirt3may contribute to
this, since it has been reported that Sirt3 knockout animals present the
highest levels of hepatic and neuronal lipid peroxidation and protein
carbonylation [61].
Additionally, we observed a signiﬁcant decrease in testicularmtDNA
content in HED-fed rats, further evidencing that the pre-diabetic condi-
tion is deleterious for the mitochondrial function. The mtDNA content
loss in this case is likely related to mitochondrial biogenesis, and PGC-
1α is connected with the co-activation of several nuclear transcriptors
such as NRF-1, NRF-2 and TFAM, directly involved in the signaling path-
ways that lead to mtDNA replication [62]. Despite that NRF-1, NRF-2
and TFAM are PGC-1α responsive genes, the unaltered levels of testicu-
lar NRF-1, NRF-2 and TFAM between HED-fed and control rats might
involve compensatory mechanisms that are known to be triggered
under oxidative stress conditions in order to maintain mitochondrial
biogenesis as those described in hepatic oxidative conditions [63].
Furthermore, though protein levels were not altered, it is expectable
that their activities are downregulated, since it has also been suggested
that Sirt3 is capable of regulating the activities of NRF1 and TFAM,which
localize in the mitochondria [16]. Additionally, mtDNA is also highly
susceptible to oxidative stress, partly due to its localization. mtDNA is
packaged into a protein-DNA complex known as amitochondrial nucle-
oid, however due to the imbalance between ROS scavenging and over-
production, which is exacerbated by disruption of PGC-1α/Sirt3 axis,
the composition of mtDNA nucleoid may be severely compromised
thus contributing to mtDNA degradation within the testicularmilieu of
pre-diabetic rats. This is supported by the fact that PGC-1α and Sirt3
are essential for ROS-detoxifying system and downregulation of both
proteins decrease the antioxidant defenses leading to compromised
mtDNA integrity [23,64].
It has also been described that DM affects mitochondrial function by
impairing ETC complexes enzymatic activities [65,66]. Although it has
been reported that citrate synthase activity is diminished under diabetic
conditions [65,67], we failed to observe signiﬁcant differences on testic-
ular citrate synthase activity in HED-fed rats, suggesting that testicular
mitochondrial integrity may be unaltered. This may be explained by
the fact that our animal model was in a prodromal stage of DM, not suf-
fering the co-morbidities related with the later stages of the disease
[68]. On the other hand, we found that HED fed rats presented a signif-
icant increase in testicular NADH reductase (complex I) activity. Thisobservation is inconsistent with previous report, using a knockout
model for Sirt3 that demonstrated reduced complex I activity [21]. In-
deed, knockout models fail to show the molecular and cellular adapta-
tions that might occur in wild type animals. Testicles are organs with
high-energy demands and sperm are highly dependent on aerobic me-
tabolism [69], so the increased mitochondrial complex I activity might
be a compensatory mechanism by testicular mitochondria in response
to metabolic changes caused by pre-diabetic state, in order to maintain
a correct electron transport chain function and guarantee an adequate
energy supply to the spermatogenic event. Furthermore, the observed
increase in mitochondrial complex I activity in HED animals is consis-
tent with the reported increase of mitochondrial oxidative capacity ob-
served in other diet-induced animalmodels [70]. After NADH oxidation,
the electrons ﬂow sequentially through cytochrome c reductase (com-
plex III), which funnels electrons from the coenzyme Q pool to cyto-
chrome c [71]. The signiﬁcant decrease observed in mitochondrial
complex III activity of HED-fed rat testicles may be caused by the de-
creased levels of Sirt3, since complex III is one of the several main tar-
gets of this deacetylase protein [22]. The decoupling in complex I and
complex III activities reverse the electron ﬂow, favoring ROS production
and impairing ATP synthesis, which could further exacerbate the pro-
oxidative environment previously described in the testicles of HED
rats by our team [14].
Disruption of PGC-1α/Sirt3 axis presented by pre-diabetic animals
induces important changes in testicular ETC function, particularly at
the level of complex I and complex III. The observed changes in ETC is
a consequence of both PGC-1α and Sirt3 deregulation andwhole testic-
ular metabolic ﬂuctuations [14], since testicles are compartmentalized
organs presenting special metabolic characteristics and energy de-
mands that confer a special microenvironment to testicular milieu
[72–75]. Although it has been reported that DM can severely affect
testicular ATPproduction [15], to our knowledge the testicular energetic
status in pre-diabetic individuals remains undisclosed. The signiﬁcant
decrease in testicular ATP levels of HED-fed rats reported herein results
from the disruption of PGC-1α/Sirt3 axiswith a consequent impairment
of ETC function. Moreover, such decrement in testicular ATP content
may arise from its hydrolysis to subsequent adenine nucleotides (ADP
and AMP) and adenosine metabolites. This hypothesis is further
supported by the lower ADP levels we observed in HED-fed rats, sug-
gesting that adenylate kinase reaction could be operating toward AMP
production. Accordingly, testicular AMP levels were signiﬁcantly in-
creased in HED rats. Noteworthy, the imbalance in adenine nucleotides
underlies a lower testicular ATP/AMP ratio, evidencing a decreased tes-
ticular AEC in HED rats. In these conditions, AMPmay arise as a key reg-
ulatorymolecule, enhancing catabolic pathways, such as glycolysis [76].
Regarding the hypoxanthine accumulation reported in testicles from
HED rats, our previous work suggested that it could result from the high
testicular glycolytic ﬂux [14]. Indeed, high hypoxanthine levels have
been correlated with an increased lactate/pyruvate ratio [77], which
may also reﬂect the redox state of cells and tissues [78]. Altogether,
our results show that HED-induced pre-diabetes downregulates both
PGC-1α and Sirt3 protein expression, disrupting this axis with a conse-
quent impairment on testicular mitochondrial bioenergetics (especially
in complex I and complex III) and testicular AEC. It leads to hypoxan-
thine accumulation that may culminate in increased oxidative damage
to testicular cells. Clearly, testicular function of HED animals is severely
affected even in a prodromal stage of diabetes. Furthermore, this is
strongly supported by previous observations by our team using this
HED model [14,42], where we showed decreased testicular weight
and compromised testicular function, including lower testicular testos-
terone content and altered sperm quality. To our knowledge, this is the
ﬁrst report giving new insights in the role of PGC-1α/Sirt3 axis in overall
testicular bioenergetics at this prodromal “silencing stage” of DM. This
topic should deserve special attention, as the subtle changes in testicular
glucose metabolism and mitochondrial bioenergetics occurring earlier in
the pathology may have a later severe negative impact in male fertility.
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